News summaryJ-Star Holding via GlobeNewswireNov 12, 2026, 12:00 PM
Alpha Tau Medical to Host Conference Call to Discuss REGAIN Trial Interim Results
Alpha Tau Medical announced it will hold a conference call and webcast on November 16, 2026, to review new interim data from its REGAIN clinical trial for recurrent glioblastoma.